Capital Advisory Group Advisory Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,577
Closed -$843K 18
2025
Q4
$843K Sell
2,577
-66
-2% -$20.9K 0.25% 83
2025
Q3
$746K Sell
2,643
-91
-3% -$26.4K 0.23% 91
2025
Q2
$763K Buy
2,734
+38
+1% +$10.8K 0.27% 83
2025
Q1
$840K Sell
2,696
-6
-0.2% -$1.77K 0.32% 80
2024
Q4
$704K Buy
2,702
+118
+5% +$35K 0.25% 88
2024
Q3
$833K Buy
2,584
+15
+0.6% +$4.91K 0.33% 71
2024
Q2
$803K Buy
2,569
+503
+24% +$148K 0.34% 65
2024
Q1
$587K Buy
2,066
+985
+91% +$288K 0.28% 81
2023
Q4
$311K Buy
1,081
+237
+28% +$64.6K 0.17% 111
2023
Q3
$227K Buy
+844
New +$211K 0.13% 131
2023
Q2
Sell
-876
Closed -$212K 88
2023
Q1
$212K Buy
+876
New +$215K 0.13% 136
2022
Q2
Sell
-291
Closed -$70K 216
2022
Q1
$70K Buy
+291
New +$66.9K 0.03% 223
2021
Q4
Sell
-485
Closed -$103K 181
2021
Q3
$103K Buy
485
+151
+45% +$34.8K 0.04% 228
2021
Q2
$81K Sell
334
-3
-0.9% -$738 0.03% 242
2021
Q1
$84K Sell
337
-519
-61% -$124K 0.03% 219
2020
Q4
$197K Sell
856
-1,633
-66% -$377K 0.08% 187
2020
Q3
$632K Buy
2,489
+1,077
+76% +$267K 0.33% 75
2020
Q2
$333K Buy
1,412
+1,376
+3,822% +$314K 0.19% 89
2020
Q1
$7K Buy
+36
New +$7.86K 0.01% 266
2019
Q4
Sell
-10
Closed -$2K 207
2019
Q3
$2K Sell
10
-21
-68% -$4.03K ﹤0.01% 380
2019
Q2
$6K Hold
31
﹤0.01% 325
2019
Q1
$6K Hold
31
﹤0.01% 311
2018
Q4
$6K Buy
31
+21
+210% +$4.1K ﹤0.01% 283
2018
Q3
$2K Hold
10
﹤0.01% 324
2018
Q2
$2K Hold
10
﹤0.01% 308
2018
Q1
$2K Buy
+10
New +$1.84K ﹤0.01% 308

Other funds holding AMGN

Capital Advisory Group Advisory Services's AMGN Position: Q1 2026 in Review

Capital Advisory Group Advisory Services sold out of Amgen (AMGN) in Q1 2026, closing a stake of 2,577 shares — an estimated $843K sold.

Capital Advisory Group Advisory Services first reported a position in AMGN in Q1 2018 and held it in 26 quarters. The position peaked at $843K in Q4 2025. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Capital Advisory Group Advisory Services reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Capital Advisory Group Advisory Services sold 2,577 Amgen shares in Q1 2026, an estimated $843K.
  • Capital Advisory Group Advisory Services first reported a position in Amgen in Q1 2018 and held it in 26 quarters.
  • Capital Advisory Group Advisory Services's Amgen position peaked at $843K in Q4 2025.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Capital Advisory Group Advisory Services's 13F filing for Q1 2026, filed 15 Apr 2026.